drugset / Trial / NCT00321191

Measurement of the Second Gas Effect on Sevoflurane in Anaesthetised Patients

NCT00321191

Phase 4 Completed 14 enrolled Austin Health
RandomizedCrossoverOpen-label

Summary

This study is investigating the "second gas effect", a phenomenon produced by the uptake of nitrous oxide (N2O) by the lungs, during the course of a typical anaesthetic. The effect is to increase the concentration of other breathed gases in the lung. These include oxygen and volatile anaesthetic agents such as sevoflurane, which are also normally administered along with N2O. We wish to i) measure the magnitude of the second gas effects on both blood and expired concentrations of sevoflurane (Part 1), and ii) see if a demonstrable difference exists between the effects on blood and expired concentrations.

Timeline

Start
2006-05
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified

Indications

No indication recorded.